ZHAO Bin,WU Zi-lu,XI Zuo-wu.Effect of Koumine on Proliferation and Apoptosis of Colorectal Cancer Cells via ROS/JNK/FoxO3a Signaling Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(24):100-108.
ZHAO Bin,WU Zi-lu,XI Zuo-wu.Effect of Koumine on Proliferation and Apoptosis of Colorectal Cancer Cells via ROS/JNK/FoxO3a Signaling Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(24):100-108. DOI: 10.13422/j.cnki.syfjx.20212422.
Effect of Koumine on Proliferation and Apoptosis of Colorectal Cancer Cells via ROS/JNK/FoxO3a Signaling Pathway
To explore the effect and underlying mechanism of koumine (Kou) at different concentrations (0, 100, 200, 400 μmol·L
-1
) on the proliferation and apoptosis of colorectal cancer HCT-116 cells.
Method
2
After 24 hours of
in vitro
intervention with HCT-116 cells by Kou, cell counting kit-8 (CCK-8) assay was used to detect its effect on cell proliferation. Flow cytometry was used to detect cell cycle, apoptosis, and reactive oxygen species (ROS) expression. Real-time quantitative polymerase chain reaction (Real-time PCR) was used to detect the mRNA expression of forkhead box O3a (FoxO3a). Cells were transfected with small interfering ribonucleic acid (siRNA). Western blot was employed to detect the protein expression of the FoxO3a target gene.
Result
2
Compared with the conditions in the blank group, Kou treatment reduced the proliferation rate of HCT-116 cells (
P
<
0.05,
P
<
0.01) in a dose-dependent manner, caused cell cycle arrest in the G
0
/G
1
phase, and induced the apoptosis of HCT-116 cells (
P
<
0.05,
P
<
0.01), which was positively correlated with the concentration of Kou. FoxO3a siRNA interference reduced the expression of FoxO3a and its downstream target genes cyclin-dependent kinase inhibitor 1A (p21), cyclin-dependent kinase inhibitor 1B (p27), and Bcl-2 interacting mediator of cell death (Bim) (
P
<
0.01). Kou treatment induced the activation of c-Jun
N
-terminal kinase (JNK) in HCT116 cells. SP600125 (JNK specific inhibitor) treatment inhibited the Kou-induced FoxO3a activation and the expression of its downstream target genes.
0.01) and JNK signal activation. The above results were significantly different from those in the blank group (
P
<
0.01).
Conclusion
2
Kou can effectively inhibit the proliferation of HCT-116 cells and promote apoptosis, and the mechanism may be related to the regulation of the ROS/JNK/FoxO3a pathway.
LS R, AT L, ISABELLE S, et al. Global patterns and trends in colorectal cancer incidence in young adults [J]. Gut, 2019, 68(12): 2179-2185.
XU Y, QIU H Q, LIU H, et al. Effects of koumine, an alkaloid of Gelsemium elegansBenth., on inflammolatory and neuropathic painmodels and possiblemechanism with allopregnanolone [J]. Pharmacol Biochem Be, 2012, 101(3): 504-514.
XU Y K, LIAO S G, NA Z, et al. Gelsemium alkaloids, immolunosuppressive agents from Gelsemium elegans [J]. Fitoterapia, 2012, 83(6): 1120-1124.
ZHANG J Y, WANG Y X. Gelsemium analgesia and the spinal glycine receptor/allopregnanolone pathway [J]. Fitoterapia, 2015, 100:35-43.
SREELATHA G, RAOM R, S G C, et al. Co-depletion of cathepsin B and uPAR induces G0/G1 arrest in glioma via FoxO3a mediated p27 upregulation [J]. PLoS One, 2010, 5(7): e11668.
NHO R S, HERGERT P. FoxO3a and disease progression [J]. World J Biol Chem, 2014, 5(3): 346-354.
GLOTZER M. Themolecular requirements for cytokinesis [J]. Science, 2005, 307(5716): 1735-1739.
MARIKO K, TOMONORI N, NORIYUKI K, et al. Isolation of gelsedine-type indole alkaloids from Gelsemium elegans and evaluation of the cytotoxic activity of gelsemium alkaloids for A431 epidermoid carcinoma cells [J]. J Nat Prod, 2006, 69(4): 715-718.
LIANG F, HUIMING W, LIN Z, et al. FoxO3a reactivationmediates the synergistic cytotoxic effects of rapamycin and cisplatin in oral squamous cell carcinoma cells [J]. Toxicol Appl Pharm, 2011, 251(1): 8-15.
ZHANG X H, CHEN Y, GAO B, et al. Apoptotic effect of koumine on human breast cancer cells and the mechanism involved[J]. Cell Biochem Biophys, 2015, 72(2): 411-416.
TRACHOOTHAM D, ALEXANDRE J, HUANG P. Targeting cancer cells by ROS-mediatedmechanisms: a radical therapeutic approach? [J]. Nat Rev Drug Discov, 2009, 8(3rd): 579-591.
HUM C T, LEE D F, XIA W, et al. IκB kinase promotes tumorigenesis through inhibition of forkhead FoxO3a [J]. Cell, 2007, 129(7): 225-237.
YANG J Y, ZONG C S, XIA W, et al. ERK promotes tumorigenesis by inhibiting FoxO3a viamDM2-mediated degradation [J]. Nat Cell Biol, 2008, 10(2): 138-148.
KONG W W,LI C,QI Q F, et al. Cardamonin induces G2/M arrest and apoptosis via activation of the JNK-FoxO3a pathway in breast cancer cells[J]. Cell Biol Inter, 2020, 44(1) : 177-188.
WANGm C, BOHMANN D, JASPER H. JNK extends life span and limits growth by antagonizing cellular and organism-wide responses to insulin signaling [J]. Cell, 2005, 121(1): 115-125.